Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hyam Levitsky Insider Profile
4 Followers
Hyam Levitsky, EVP, Research and Chief Scientific Officer at Juno Therapeutics, holds 145.00K shares in Juno Therapeutics (Ticker: JUNO), holds ― shares in Replimune Group (Ticker: REPL), holds 560.54K shares in Century Therapeutics (Ticker: IPSC).
Hyam Levitsky Juno Therapeutics (JUNO)EVP, Research and Chief Scientific Officer
Juno Therapeutics (JUNO)
EVP, Research and Chief Scientific Officer
Not Ranked
Hyam Levitsky has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Hyam Levitsky holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Hyam Levitsky
Hyam Levitsky's Trading History
Juno Therapeutics
Feb 09, 2017
―
Uninformative Buy
―
$12.61M
Replimune Group
―
Director
―
―
Century Therapeutics
Mar 11, 2024
President of R&D
Uninformative Buy
―
$1.61M
Agenus
Mar 03, 2009
Director
Uninformative Buy
―
$179.75K
List of latest transactions for each holding click on a transaction to see Hyam Levitsky's performance on stock
You May Also Like
Hyam Levitsky insider profile FAQ
What is the percentage of profitable transactions made by Hyam Levitsky?
The percentage of profitable transactions made by Hyam Levitsky is ―.
What is the average return per transaction made by Hyam Levitsky?
The average return per transaction made by Hyam Levitsky is ―.
What stocks does Hyam Levitsky hold?
Hyam Levitsky holds: JUNO, REPL, IPSC, AGEN stocks.
What was Hyam Levitsky’s latest transaction?
Hyam Levitsky latest transaction was an Uninformative Buy of ―.
What was Hyam Levitsky's most profitable transaction?
Hyam Levitsky’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Hyam Levitsky's role in Juno Therapeutics?
Hyam Levitsky's role in Juno Therapeutics is EVP, Research and Chief Scientific Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.